PMID: 25790691Jan 1, 2014Paper

Melatonin and arterial hypertension: from understanding pathogenesis to therapeutic modalities

Klinicheskaia meditsina
A D Pal'man, S I Rapoport

Abstract

Biological rhythms are driven by the hypothalamic circadian pacemaker. Its action is mediated through epiphyseal melatonin that transmits regulatory signals directly to target organs. Circadian fluctuations of arterial pressure suggest participation of melatonin in regulation of this important indicator of cardiovascular activity. Melatonin is a key endogenous hypotensive factor. Some studies demonstrated that additional prescription ofmelatonin to patients with nocturnal hypertension refractory to traditional hypotensive agents significantly lowered arterial pressure during sleep. Moreover, melatonin was shown to exert meteo- and magnetoprotective action and thereby reduce the dependence ofpatients with arterial hypertension on the adverse environmental factors.

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

The New England Journal of Medicine
J Arendt
Sleep Medicine Reviews
Frank A J L Scheer, Charles A Czeisler
Sheng li ke xue jin zhan [Progress in physiology]
Y Rao, B S Ku
© 2021 Meta ULC. All rights reserved